{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:52:30Z","timestamp":1791042750586,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":1050,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.virol.2010.06.014","type":"journal-article","created":{"date-parts":[[2010,7,2]],"date-time":"2010-07-02T04:23:20Z","timestamp":1278044600000},"page":"243-252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["The neurovirulence and neuroinvasiveness of chimeric tick-borne encephalitis\/dengue virus can be attenuated by introducing defined mutations into the envelope and NS5 protein genes and the 3\u2032 non-coding region of the genome"],"prefix":"10.1016","volume":"405","author":[{"given":"Amber R.","family":"Engel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander A.","family":"Rumyantsev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga A.","family":"Maximova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Speicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Heiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian R.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander G.","family":"Pletnev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2010.06.014_bib1","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1016\/j.vaccine.2010.02.001","article-title":"Vaccine failures after active immunisation against tick-borne encephalitis","volume":"28","author":"Andersson","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2010.06.014_bib2","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.1128\/JVI.02188-08","article-title":"NS5 of dengue virus mediates STAT2 binding and degradation","volume":"83","author":"Ashour","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.06.014_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/biol.1997.0056","article-title":"Yellow fever vaccines","volume":"25","author":"Barrett","year":"1997","journal-title":"Biologicals"},{"key":"10.1016\/j.virol.2010.06.014_bib4","series-title":"Vaccines","first-page":"1039","article-title":"Tick-borne encephalitis virus vaccine","author":"Barrett","year":"2004"},{"key":"10.1016\/j.virol.2010.06.014_bib5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00415-004-0329-z","article-title":"Two severe cases of tick-borne encephalitis despite complete active vaccination\u2014the significance of neutralizing antibodies","volume":"251","author":"Bender","year":"2004","journal-title":"J. Neurol."},{"key":"10.1016\/j.virol.2010.06.014_bib6","doi-asserted-by":"crossref","first-page":"9731","DOI":"10.1128\/JVI.75.20.9731-9740.2001","article-title":"Chemical mutagenesis of dengue virus type 4 yields mutant viruses which are temperature sensitive in vero cells or human liver cells and attenuated in mice","volume":"75","author":"Blaney","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.06.014_bib7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1006\/viro.2002.1528","article-title":"Genetic basis of attenuation of dengue virus type 4 small plaque mutants with restricted replication in suckling mice and in SCID mice transplanted with human liver cells","volume":"300","author":"Blaney","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.virol.2010.06.014_bib8","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1016\/S0264-410X(03)00487-0","article-title":"Mutations which enhance the replication of dengue virus type 4 and an antigenic chimeric dengue virus type 2\/4 vaccine candidate in Vero cells","volume":"21","author":"Blaney","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2010.06.014_bib9","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1016\/j.vaccine.2008.05.075","article-title":"Evaluation of St. Louis encephalitis virus\/dengue virus type 4 antigenic chimeric viruses in mice and rhesus monkeys","volume":"26","author":"Blaney","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2010.06.014_bib10","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/INF.0b013e318162a18e","article-title":"A fatal tick bite occurring during the course of tick-borne encephalitis vaccination","volume":"27","author":"Brauchli","year":"2008","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.virol.2010.06.014_bib11","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1089\/jir.2009.0069","article-title":"Mechanisms of evasion of the type I interferon antiviral response by flaviviruses","volume":"29","author":"Diamond","year":"2009","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.virol.2010.06.014_bib12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4269\/ajtmh.2001.65.405","article-title":"Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3\u2032-untranslated region","volume":"65","author":"Durbin","year":"2001","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.virol.2010.06.014_bib13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4161\/hv.2.4.2944","article-title":"The live attenuated dengue serotype 1 vaccine rDEN1Delta30 is safe and highly immunogenic in healthy adult volunteers","volume":"2","author":"Durbin","year":"2006","journal-title":"Hum. Vaccin."},{"key":"10.1016\/j.virol.2010.06.014_bib14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4161\/hv.2.6.3494","article-title":"rDEN2\/4Delta30(ME), a live attenuated chimeric dengue serotype 2 vaccine is safe and highly immunogenic in healthy dengue-naive adults","volume":"2","author":"Durbin","year":"2006","journal-title":"Hum. Vaccin."},{"key":"10.1016\/j.virol.2010.06.014_bib15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0166-3542(02)00206-1","article-title":"Tick-borne encephalitis","volume":"57","author":"Gritsun","year":"2003","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virol.2010.06.014_bib16","series-title":"Vaccine","first-page":"919","article-title":"Japanese encephalitis vaccines","author":"Halstead","year":"2004"},{"key":"10.1016\/j.virol.2010.06.014_bib17","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1128\/JVI.76.2.525-531.2002","article-title":"Paired charge-to-alanine mutagenesis of dengue virus type 4 NS5 generates mutants with temperature-sensitive, host range, and mouse attenuation phenotypes","volume":"76","author":"Hanley","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.06.014_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-3527(03)60001-1","article-title":"Molecular determinants of virulence: the structural and functional basis for flavivirus attenuation","volume":"60","author":"Hurrelbrink","year":"2003","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.virol.2010.06.014_bib19","doi-asserted-by":"crossref","first-page":"5414","DOI":"10.1128\/JVI.79.9.5414-5420.2005","article-title":"Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression","volume":"79","author":"Jones","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.06.014_bib20","first-page":"261","article-title":"Autonomic involvement in tick-borne encephalitis (TBE): report of five cases","volume":"11","author":"Kleiter","year":"2006","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.virol.2010.06.014_bib21","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s10354-006-0318-1","article-title":"Tick-borne encephalitis\u2014a European health challenge. Conference report of the 8th meeting of the International Scientific Working Group on Tick-borne Encephalitis (ISW TBE)","volume":"156","author":"Kunze","year":"2006","journal-title":"Wien. Med. Wochenschr."},{"key":"10.1016\/j.virol.2010.06.014_bib22","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1016\/j.vaccine.2009.02.069","article-title":"Characterization of neutralizing antibodies to Far Eastern of tick-borne encephalitis virus subtype and the antibody avidity for four tick-borne encephalitis vaccines in human","volume":"27","author":"Leonova","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2010.06.014_bib23","series-title":"Fields Virology","first-page":"1101","article-title":"Flaviviridae: the viruses and their replication","author":"Lindenbach","year":"2007"},{"key":"10.1016\/j.virol.2010.06.014_bib24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.virusres.2005.04.007","article-title":"Steps of the tick-borne encephalitis virus replication cycle that affect neuropathogenesis","volume":"111","author":"Mandl","year":"2005","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2010.06.014_bib25","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.1128\/JVI.00172-08","article-title":"Comparative neuropathogenesis and neurovirulence of attenuated flaviviruses in nonhuman primates","volume":"82","author":"Maximova","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.06.014_bib26","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1086\/605847","article-title":"Dengue virus NS5 inhibits interferon-alpha signaling by blocking signal transducer and activator of transcription 2 phosphorylation","volume":"200","author":"Mazzon","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2010.06.014_bib27","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1586\/14760584.4.4.553","article-title":"Yellow fever vaccine","volume":"4","author":"Monath","year":"2005","journal-title":"Expert Rev. Vaccines."},{"key":"10.1016\/j.virol.2010.06.014_bib28","doi-asserted-by":"crossref","first-page":"6936","DOI":"10.1128\/JVI.02830-06","article-title":"Identification of residues critical for the interferon antagonist function of Langat virus NS5 reveals a role for the RNA-dependent RNA polymerase domain","volume":"81","author":"Park","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.06.014_bib29","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1073\/pnas.95.4.1746","article-title":"Attenuation of the Langat tick-borne flavivirus by chimerization with mosquito-borne flavivirus dengue type 4","volume":"95","author":"Pletnev","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2010.06.014_bib30","doi-asserted-by":"crossref","first-page":"10532","DOI":"10.1073\/pnas.89.21.10532","article-title":"Construction and characterization of chimeric tick-borne encephalitis\/dengue type 4 viruses","volume":"89","author":"Pletnev","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2010.06.014_bib31","doi-asserted-by":"crossref","first-page":"4956","DOI":"10.1128\/jvi.67.8.4956-4963.1993","article-title":"Chimeric tick-borne encephalitis and dengue type 4 viruses: effects of mutations on neurovirulence in mice","volume":"67","author":"Pletnev","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.06.014_bib32","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.1016\/j.vaccine.2006.06.008","article-title":"Chimeric West Nile\/dengue virus vaccine candidate: preclinical evaluation in mice, geese and monkeys for safety and immunogenicity","volume":"24","author":"Pletnev","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2010.06.014_bib33","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.vaccine.2007.11.009","article-title":"TBE infection in an incomplete immunized person at-risk who lives in a high-endemic area\u2014impact on current recommendations for immunization of high-risk groups","volume":"26","author":"Plisek","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2010.06.014_bib34","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.micinf.2007.12.005","article-title":"Tick-borne encephalitis incidence in Central and Eastern Europe: consequences of political transition","volume":"10","author":"Randolph","year":"2008","journal-title":"Microbes Infect."},{"key":"10.1016\/j.virol.2010.06.014_bib35","first-page":"493","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hyg."},{"key":"10.1016\/j.virol.2010.06.014_bib36","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s12026-008-8065-6","article-title":"Tick-borne flaviviruses: dissecting host immune responses and virus countermeasures","volume":"43","author":"Robertson","year":"2009","journal-title":"Immunol. Res."},{"key":"10.1016\/j.virol.2010.06.014_bib37","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.vaccine.2005.07.067","article-title":"Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys","volume":"24","author":"Rumyantsev","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2010.06.014_bib38","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1128\/JVI.80.3.1427-1439.2006","article-title":"A tick-borne Langat virus mutant that is temperature sensitive and host range restricted in neuroblastoma cells and lacks neuroinvasiveness for immunodeficient mice","volume":"80","author":"Rumyantsev","year":"2006","journal-title":"J. Virol."},{"issue":"Suppl 1","key":"10.1016\/j.virol.2010.06.014_bib39","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/S0264-410X(02)00812-5","article-title":"Epidemiology and ecology of TBE relevant to the production of effective vaccines","volume":"21","author":"Suss","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2010.06.014_bib40","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1128\/JVI.77.2.1653-1657.2003","article-title":"A live, attenuated dengue virus type 1 vaccine candidate with a 30-nucleotide deletion in the 3\u2032 untranslated region is highly attenuated and immunogenic in monkeys","volume":"77","author":"Whitehead","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.06.014_bib41","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.vaccine.2007.12.015","article-title":"Evaluation of the Langat\/dengue 4 chimeric virus as a live attenuated tick-borne encephalitis vaccine for safety and immunogenicity in healthy adult volunteers","volume":"26","author":"Wright","year":"2008","journal-title":"Vaccine"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004268221000396X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004268221000396X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:06:35Z","timestamp":1758585995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004268221000396X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S004268221000396X"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2010.06.014","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The neurovirulence and neuroinvasiveness of chimeric tick-borne encephalitis\/dengue virus can be attenuated by introducing defined mutations into the envelope and NS5 protein genes and the 3\u2032 non-coding region of the genome","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2010.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}